Separating research from development: Evidence from the pharmaceutical industry
From an organisational point of view, corporate research and development (R&D) has always been viewed as one function. That view, however, has undergone some changes in the last few years, and many major corporations have changed their R&D organisation or re-thought their overall structure on the basis of their technical competencies. With the example of the pharmaceutical industry, in which R&D has a particularly strong role to play, Vittorio Chiesa reports on a survey of nine major pharmaceutical firms which have recently instigated such changes. Among the changes are a separation of the 'research' and 'development' activities organisationally and sometimes physically. The author puts forward explanations for this trend and weighs the advantages and disadvantages.
Year of publication: |
1996
|
---|---|
Authors: | Chiesa, Vittorio |
Published in: |
European Management Journal. - Elsevier, ISSN 0263-2373. - Vol. 14.1996, 6, p. 638-647
|
Publisher: |
Elsevier |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
HOW TO USE PILOT PROJECTS TO IMPLEMENT OPEN INNOVATION
BOSCHERINI, LORENZO, (2010)
-
Urbinati, Andrea, (2018)
-
Research Section - Patterns of collaboration along the bio-pharmaceutical innovation process
Chiaroni, Davide, (2008)
- More ...